Evidence map›Paper›PMID 36994227›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) in mild Alzheimer's disease.

Hugo Cogo-Moreira, Saffire H Krance, Che-Yuan Wu, Krista L Lanctôt, Nathan Herrmann, Sandra E Black, Bradley J MacIntosh, Jennifer S Rabin, Michael Eid, Walter Swardfager and 1 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Brain network dynamics in patients with single- and multiple-domain amnestic mild cognitive impairment.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Hugo Cogo-MoreiraDepartment of Education ICT and Learning Østfold University College Halden Norway.
Saffire H KranceSchulich School of Medicine and Dentistry University of Western Ontario London Ontario Canada.
Che-Yuan WuSandra Black Centre for Brain Resilience and Recovery Sunnybrook Research Institute Toronto Ontario Canada.
Krista L LanctôtSandra Black Centre for Brain Resilience and Recovery Sunnybrook Research Institute Toronto Ontario Canada.
Nathan HerrmannHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.
Sandra E BlackSandra Black Centre for Brain Resilience and Recovery Sunnybrook Research Institute Toronto Ontario Canada.
Bradley J MacIntoshSandra Black Centre for Brain Resilience and Recovery Sunnybrook Research Institute Toronto Ontario Canada.
Jennifer S RabinHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.
Michael EidDepartment of Education and Psychology Freie Universität Berlin Berlin Germany.
Walter SwardfagerSandra Black Centre for Brain Resilience and Recovery Sunnybrook Research Institute Toronto Ontario Canada.
Alzheimer's Disease Neuroimaging Initiative
Østfold University College · NOSunnybrook Health Science Centre · CASunnybrook Research InstituteFreie Universität Berlin · DEHealth Sciences Centre · CASunnybrook Hospital · CAUniversity of Toronto · CAWestern University · CA

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Background: The Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) is used to assess decline in memory, language, and praxis in Alzheimer's disease (AD). Methods: A latent state-trait model with autoregressive effects was used to determine how much of the ADAS-Cog item measurement was reliable, and of that, how much of the information was occasion specific (state) versus consistent (trait or accumulated from one visit to the next). Results: Participants with mild AD ( Conclusions: Although the ADAS-Cog was designed to track cognitive decline, most items were unreliable, and each item captured different amounts of information related to occasion-specific, trait, and accumulated effects of AD over time. These latent properties complicate the interpretation of trends seen in ordinary statistical analyses of trials and other clinical studies with repeated ADAS-Cog item measures. Highlights: Studies have described unfavorable psychometric properties of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), bringing into question its ability to track changes in cognition uniformly over time. There remains a need to estimate how much of the ADAS-Cog measurement is reliable, of that how much is occasion specific versus consistent, and of the consistent information, how much represents enduring traits versus autoregressive effects (i.e., effects of Alzheimer's disease [AD] progression carried over from one assessment to the next).A latent state-trait model with autoregressive effects in mild AD found most items to be unreliable, and each item to capture different amounts of occasion-specific, trait, and autoregressive information. Language items, specifically, naming and the memory item word recall, were the most reliable.Psychometric idiosyncrasies of individual items complicate the interpretation of their summed score, biasing ordinary statistical analyses of repeated measures in mild AD. Future studies should consider item trajectories individually.

Indexed as

Alzheimer's diseaseAlzheimer's Disease Assessment Scale Cognitive Subscalecognitionlatent state–trait autoregressive modelstructural equation modelling

Identifiers

PMID36994227
PMCPMC10040491
OpenAlexW4360985619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.